| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
LeMaitre Vascular, Inc.$102.74
+0.34 (+0.33%)
F 17Pipeline Score MedTech · Clinical
Market Cap
2.23 B
EPS
2.75
P/E Ratio
36.02 $
Value Trade
19.52 M
SEC Financials
Q1 2026Dilution Risk
Revenue
66.55 M
R&D Expenses
4.06 M
Operating CF
15.09 M
Total Assets
629.53 M
Total Liabilities
222.90 M
Equity
406.62 M
D/E Ratio
12,345
-1.49 %
Week
-13.3 %
1 Month
5.96 %
3 Month
15.5 %
6 Month
97.04 %
5 Year
1,403.85 %
All Time
Cash Data
Cash Position
367.23 M
Monthly Burn
-
Runway
12,345 mo
Burn Trend
StableSEC Filing
May 6, 2026
Overview
Volume
311.46 K
52 Week Range
79.01 - 118.01
% held by Insiders
6.9 %
% held by Institutions
98.2 %
Enterprise Value
2.06 B
Total Shares
22.84 M
Short %
6.42 %
Float Shares
21.15 M
Company Description
locked
Upcoming Catalyst
Drug Pipeline Intelligence
F17
Pipeline Score -
Pipeline ValueValuation Signal
0
Drugs Scored—
rNPV / MCap Top 15%
Small Cap (rank 775 of 911)
Percentile RankLeMaitre Vascular, Inc. has significant pipeline risk (17/100).
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in LMAT
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
LMAT Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
| 2026-07-17 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-07-17 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-07-17 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
LMATLeMaitre to Participate at Upcoming Investor Conferences in June
LeMaitre Vascular, Inc. will participate in two investor conferences in June 2026. The Jefferies Global Healthcare Conference is scheduled for June 3, and the Goldman Sachs Annual Global Healthcare Conference will take place on June 10. These events will provide management with opportunities to engage with investors and discuss the company's developments.
Read more →LMATLeMaitre to Present at the Bank of America Healthcare Conference
LeMaitre Vascular, Inc. will present at the Bank of America Healthcare Conference on May 13, 2026, at 5:15 PM PT. The company specializes in devices and services for peripheral vascular disease, impacting over 200 million people globally. This presentation highlights their commitment to engaging with the healthcare community.
Read more →LMATLeMaitre Q1 2026 Financial Results BURLINGTON, MA
LeMaitre Vascular, Inc. announced strong financial results for Q1 2026, with a reported revenue growth and record sales in multiple product categories. The company achieved a gross margin of 72.7%, an increase attributed to higher pricing and manufacturing efficiencies. Full-year guidance was optimistic, anticipating 12% sales growth and a 26% increase in adjusted EPS. Additionally, a quarterly dividend of $0.25/share was declared, underscoring the company's commitment to shareholder returns.
Read more →LMATLeMaitre Q1 2026 Financial Results
LeMaitre Vascular, Inc. reported strong Q1 2026 financial results with sales of $66.6 million, an 11% increase from the previous year. The company also announced a quarterly dividend of $0.25 per share and provided optimistic guidance for the full year, projecting 12% sales growth and 26% adjusted EPS growth. Key product lines, including Artegraft, showed significant growth, particularly in international markets.
Read more →LMATLeMaitre Will Announce First Quarter 2026 Earnings Results on May 5, 2026
LeMaitre Vascular, Inc. will release its first quarter 2026 financial results on May 5, 2026, after market close. A conference call is scheduled for the same day at 5:00 PM EDT to discuss the results and company outlook. The event reflects the company's ongoing commitment to transparency and investor relations.
Read more →LMATLeMaitre to Present at the 25th Annual Needham Virtual Healthcare Conference
LeMaitre Vascular, Inc. announced its participation in the 25th Annual Needham Virtual Healthcare Conference scheduled for April 16, 2025. The presentation will be led by management, highlighting the company's commitment to addressing peripheral vascular disease. LeMaitre specializes in devices and services for vascular surgeons, catering to a significant global patient population.
Read more →LMATLeMaitre to Participate at Upcoming Investor Conferences in March 2026
LeMaitre Vascular, Inc. will participate in five investor conferences in March 2026, including notable events like the Leerink Partners Global Healthcare Conference and the Barclays Annual Global Healthcare Conference. Management will present and be available for one-on-one meetings, aiming to strengthen investor relations and showcase their vascular devices.
Read more →LMATLeMaitre to Participate at Upcoming Investor Conferences in March
LeMaitre Vascular, Inc. will participate in five investor conferences throughout March 2026, including the Leerink Partners and Barclays Annual Global Healthcare Conference. Management is scheduled to present and will be readily available for one-on-one meetings during these events. This engagement indicates the company's proactive approach in connecting with investors while emphasizing its role in treating peripheral vascular disease, a major global health issue.
Read more →LMAT▲ +24.4%on this newsshared move
LeMaitre Q4 2025 Financial Results
LeMaitre Vascular, Inc. reported strong Q4 2025 results with a 16% increase in sales and a 47% rise in operating income. The company announced a quarterly dividend increase of 25% and provided optimistic guidance for 2026, projecting $280 million in sales. Growth was driven by strong performance in grafts, valvulotomes, and carotid shunts across various regions.
Read more →LMATLeMaitre Q4 2025 Financial Results BURLINGTON, MA
LeMaitre Vascular, Inc. reported strong Q4 2025 financial results, with sales driven by significant growth in key product categories. The company announced a 25% increase in its quarterly dividend and provided optimistic guidance for 2026, anticipating sales of $280 million and adjusted operating income growth. The results highlighted a gross margin increase and overall operational efficiency improvements. The outlook for the upcoming year appears robust, reflecting confidence in the company's strategic initiatives.
Read more →LMATLeMaitre Will Announce Fourth Quarter 2025 Earnings Results February 25, 2026
LeMaitre Vascular, Inc. has announced that it will release its fourth quarter 2025 financial results on February 25, 2026, after market close. A conference call is scheduled for the same day at 5:00 PM EST to discuss the results and company outlook. The call will be accessible to registered participants.
Read more →LMATLeMaitre to Participate in Upcoming Investor Conferences
LeMaitre Vascular, Inc. has announced its participation in three upcoming investor conferences. CFO Dorian LeBlanc will present at the Jefferies London Healthcare Conference and the Piper Sandler 37th Annual Healthcare Conference, while President David Roberts will present at the Wolfe Research 7th Annual Healthcare Conference. These events aim to enhance investor relations and showcase the company's offerings in peripheral vascular disease treatment.
Read more →LMATLeMaitre Q3 2025 Financial Results
LeMaitre Vascular, Inc. reported strong Q3 2025 financial results, with significant sales growth driven by grafts and shunts. The international launch of Artegraft contributed to a 33% increase in sales. The company announced a quarterly dividend of $0.20 per share and provided positive guidance for the remainder of the year. Adjusted gross margins improved due to higher selling prices and operational efficiencies.
Read more →LMATLeMaitre Q3 2025 Financial Results BURLINGTON, MA
LeMaitre Vascular, Inc. reported strong Q3 2025 financial results with notable sales growth in its vascular devices. The company's adjusted gross margin increased to 70.8%, aided by rising average selling prices and greater manufacturing efficiencies. CEO George LeMaitre expressed optimism regarding the company's growth trajectory and highlighted the successful international launch of Artegraft. Additionally, the company announced a quarterly dividend of $0.20 per share, affirming its financial health.
Read more →LMATLeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025
LeMaitre Vascular, Inc. will announce its third quarter 2025 earnings on November 6, 2025, after market close. A conference call is scheduled for the same day at 5:00 PM EST to discuss the results and company outlook. The company specializes in devices for peripheral vascular disease.
Read more →LMATLeMaitre to Participate at Upcoming Investor Conferences in September
LeMaitre Vascular, Inc. announced its participation in four investor conferences scheduled for September 2025. CFO Dorian LeBlanc will represent the company at each event, presenting to potential investors and stakeholders. These conferences include the Wells Fargo Healthcare Conference, the Cantor Global Healthcare Conference, the Morgan Stanley Global Healthcare Conference, and a virtual event by Barrington Research. This initiative reflects the company's commitment to maintaining strong investor communication and enhancing its market presence.
Read more →LMATLeMaitre Q2 2025 Financial Results
LeMaitre Vascular, Inc. reported robust Q2 2025 financial results with sales of $64.2 million, marking a 15% increase year-over-year. The company achieved a gross margin of 70.0%, which reflects improvements in pricing and efficiencies. Additionally, earnings per diluted share rose to $0.60, a 16% gain from the prior year. The firm also announced a quarterly dividend of $0.20/share, signaling a commitment to returning value to shareholders.
Read more →LMATLeMaitre Will Announce Second Quarter 2025 Earnings Results August 5, 2025
LeMaitre Vascular, Inc. (Nasdaq:LMAT) has announced that it will release its second quarter 2025 financial results on August 5, 2025, after the market closes. The company will hold a conference call at 5:00 PM EDT on the same day to discuss the results and provide insights into business highlights and future outlook. LeMaitre specializes in devices and services for treating peripheral vascular disease, which impacts over 200 million people globally.
Read more →LMATLeMaitre to Present at the Bank of America Securities 2025 Healthcare Conference
LeMaitre Vascular, Inc. will present at the Bank of America Securities 2025 Healthcare Conference on May 13, 2024. David Roberts, the President of LeMaitre, will lead the presentation at the Encore at the Wynn Hotel in Las Vegas, NV. The company specializes in devices for treating peripheral vascular disease.
Read more →LMATLeMaitre Q1 2025 Financial Results
LeMaitre Vascular, Inc. (LMAT) reported a strong financial performance for Q1 2025, with sales reaching $59.9 million, a 12% increase and a 13% organic growth. The company also announced a quarterly dividend of $0.20 per share, demonstrating solid cash position of $302.5 million. Despite the positive results, operating expenses increased by 16%, and the company ended its agreement for a porcine patch distribution, which may affect future sales. Overall, the company raised its sales guidance for 2025, reflecting confidence in ongoing momentum.
Read more →LMATLeMaitre Will Announce First Quarter 2025 Earnings Results May 1, 2025
LeMaitre Vascular, Inc. will release its financial results for the first quarter of 2025 on May 1, 2025, after market close. A conference call is scheduled for 5:00 PM EDT the same day to discuss these results and provide insights into the company's outlook. LeMaitre specializes in devices, implants, and services for treating peripheral vascular disease, impacting millions globally.
Read more →LMATLeMaitre to Present at the 24th Annual Needham Virtual Healthcare Conference
LeMaitre Vascular, Inc. will present at the 24th Annual Needham Virtual Healthcare Conference on April 8, 2025. This event highlights the company's commitment to addressing peripheral vascular disease, which impacts over 200 million people globally. The presentation is scheduled for 3:45 PM EDT.
Read more →LMATLeMaitre Q4 2024 Financial Results
LeMaitre Vascular, Inc. reported its Q4 2024 financial results, showing a 14% increase in sales compared to the previous year, reaching $55.7 million. The company also announced a quarterly dividend increase of 25% to $0.20 per share. Operating income rose 26% to $12.9 million, supported by higher average selling prices and manufacturing efficiencies. The company provided guidance for Q1 2025, projecting sales growth and consistent gross margins, demonstrating optimism about future performance.
Read more →LMATLeMaitre Will Announce Fourth Quarter 2024 Earnings Results February 27, 2025
LeMaitre Vascular, Inc. will announce its fourth quarter 2024 financial results on February 27, 2025, after market close. A conference call has been arranged for that same day at 5:00 PM EST, where the company will discuss its results and outlook. This announcement highlights the company's ongoing commitment to its stakeholders and offers insights into its operations within the peripheral vascular disease market.
Read more →LMAT▼ -8.5%on this news
LeMaitre Vascular Announces Proposed Convertible Senior Notes Offering BOSTON, MA
LeMaitre Vascular, Inc. announced its intention to conduct a private offering of $150 million in Convertible Senior Notes, due 2030. The offering will be targeted at qualified institutional buyers and may include an additional $22.5 million purchase option. The raised funds will be utilized for working capital and potential acquisitions. The notes will carry conversion options for investors, providing flexibility for potential equity participation.
Read more →LMAT▼ -8.5%on this news
LeMaitre Vascular Prices $150 Million Convertible Senior Notes BOSTON, MA
LeMaitre Vascular has announced the pricing of $150 million in 2.50% Convertible Senior Notes due in 2030. The issuance is aimed at qualified institutional buyers, with settlement planned for December 19, 2024. LeMaitre expects to generate about $145.9 million in net proceeds, which will be used for working capital and potentially for acquisitions. The notes allow for conversion into common stock starting August 1, 2029, with certain conditions and a premium over the current stock price.
Read more →LMATLeMaitre to Participate at Upcoming Investor Conferences in December
LeMaitre Vascular, Inc. has announced its participation in two investor conferences in December 2024. President David Roberts will present at the Piper Sandler 36th Annual Healthcare Conference on December 3 and at the Stifel 'MedTech Madness' West Coast Bus Tour on December 12. These presentations aim to inform investors about the company's innovative vascular devices and services targeting peripheral vascular disease. The company's commitment to investor engagement suggests a proactive approach in the market.
Read more →LMAT▲ +7.3%on this news
LeMaitre to Participate at Upcoming Investor Conferences in November
LeMaitre Vascular, Inc. (Nasdaq:LMAT) has announced its participation in three upcoming investor conferences scheduled for November 2024. David Roberts, the company's President, will present at each of the conferences, including UBS Global Healthcare, Stifel's 2024 Healthcare Conference, and Wolfe Research Healthcare Conference. This engagement with investors demonstrates LeMaitre's proactive approach in communicating their business strategy and market presence, particularly in the vascular health sector.
Read more →LMATLeMaitre Q3 2024 Financial Results
LeMaitre (Nasdaq:LMAT) reported strong Q3 2024 financial results with a 16% increase in sales compared to Q3 2023. The company's gross margin rose to 67.8%, primarily due to price increases and enhanced manufacturing efficiency. Operating income surged by 43%, and the company has announced a quarterly dividend of $0.16 per share. Despite these positives, rising operating expenses and competitive pressures remain areas of concern for future performance.
Read more →LMATLeMaitre Will Announce Third Quarter 2024 Earnings Results October 31, 2024
LeMaitre Vascular, Inc. will announce its third quarter 2024 earnings results on October 31, 2024, following market close. A conference call is scheduled for the same day at 5:00 PM ET to discuss the financial results and provide insights into business highlights and future outlook. LeMaitre specializes in devices and services for treating peripheral vascular disease, impacting over 200 million individuals globally.
Read more →LMATLeMaitre Q2 2024 Financial Results
LeMaitre Vascular, Inc. (Nasdaq: LMAT) reported strong financial results for Q2 2024, with sales increasing by 11% compared to the same quarter last year. The company achieved a gross margin of 68.9%, driven by manufacturing efficiencies, and operating income rose by 52%. LeMaitre also announced guidance for Q3 and full year 2024, projecting continued growth. In addition to a positive financial outlook, the Board approved a quarterly dividend of $0.16 per share, set to be paid on August 29, 2024.
Read more →LMATLeMaitre Will Announce Second Quarter 2024 Earnings Results August 1, 2024
LeMaitre Vascular, Inc. has announced the release date for its second quarter 2024 earnings results, which will take place on August 1, 2024, after market close. Accompanying the results, the company will host a conference call at 5:00 PM ET the same day to discuss financial details, business highlights, and future outlook. The company specializes in devices and treatments for peripheral vascular disease, a condition impacting over 200 million people worldwide.
Read more →LMATLeMaitre to Present at the Jefferies Global Healthcare Conference
LeMaitre Vascular, Inc. announced that CEO George W. LeMaitre will present at the 2024 Jefferies Global Healthcare Conference scheduled for June 6, 2024. The conference will take place in New York City and is expected to provide an opportunity for the company to showcase its innovative vascular devices. LeMaitre specializes in solutions for peripheral vascular disease, which impacts over 200 million individuals worldwide.
Read more →LMATLeMaitre Q1 2024 Financial Results
LeMaitre Vascular, Inc. reported positive financial results for Q1 2024, highlighting a 14% increase in sales to $53.5 million and a 64% rise in net income to $9.9 million. The company's gross margin improved to 68.6%, supported by efficiency gains and price increases. Additionally, a quarterly dividend of $0.16 per share was declared, demonstrating a commitment to shareholder value. Looking ahead, LeMaitre provided optimistic guidance for Q2 and the full year, suggesting strong operational performance.
Read more →LMATLeMaitre Will Announce First Quarter 2024 Earnings Results May 2, 2024
LeMaitre Vascular, Inc. has announced that it will release its financial results for the first quarter of 2024 on May 2, 2024, after market close. Following the release, a conference call will be held at 5:00 PM ET to discuss the results and the company's business outlook. This event highlights LeMaitre's commitment to keeping its stakeholders informed about its performance and strategic direction.
Read more →LMATLeMaitre to Present at the 23rd Annual Needham Virtual Healthcare Conference
LeMaitre Vascular, Inc. has announced that its Chief Financial Officer, JJ Pellegrino, will present virtually at the 23rd Annual Needham Virtual Healthcare Conference on April 10, 2024. The company specializes in developing and marketing devices for peripheral vascular disease, which affects over 200 million people globally. This presentation reflects LeMaitre's active engagement in the healthcare sector and its focus on addressing the needs of vascular surgeons.
Read more →LMATLeMaitre Q4 2023 Financial Results
LeMaitre Vascular, Inc. (LMAT) released its Q4 2023 financial results, showing a strong 19% increase in sales year-over-year, totaling $48.9 million. The company reported a gross margin improvement to 68.1%, alongside a significant increase in operating income of 46%. Additionally, LeMaitre announced a quarterly dividend of $0.16 per share and provided optimistic guidance for 2024, projecting steady growth in both sales and operating margins. The positive trajectory reflects the company's successful performance in key product categories across various regions.
Read more →LMAT▼ -5.2%on this news
LeMaitre Will Announce Fourth Quarter 2023 Earnings Results February 27, 2024
LeMaitre Vascular, Inc. has announced it will release its fourth quarter 2023 financial results on February 27, 2024. The announcement includes a scheduled conference call at 5:00 PM ET to discuss the results and business highlights. The company, which specializes in vascular devices and services, emphasizes its commitment to addressing peripheral vascular disease, impacting over 200 million people globally.
Read more →LMATLeMaitre to Present at the 26th Annual Needham Growth Conference
LeMaitre Vascular, Inc. will present at the 26th Annual Needham Growth Conference on January 19, 2024, at 11:00 AM ET. JJ Pellegrino, the Chief Financial Officer, will be leading the presentation. The company specializes in devices and services for peripheral vascular disease, a condition affecting over 200 million people globally. This participation may enhance LeMaitre's presence and engagement in the vascular surgery community.
Read more →LMATLeMaitre Q3 2023 Financial Results
LeMaitre Vascular, Inc. reported its Q3 2023 financial results with notable increases in sales and profitability, driven by price increases and a recovery in hospital activity. Sales reached $47.4 million, reflecting a 21% year-over-year growth, while operating income also rose significantly by 49%. The company's cash position improved to $97 million, allowing for a $0.14 quarterly dividend to shareholders. For the upcoming quarter and full year, the company has issued positive sales and earnings guidance, reinforcing growth expectations.
Read more →LMATLeMaitre Will Announce Third Quarter 2023 Earnings Results November 1, 2023
LeMaitre Vascular, Inc. has announced that it will release its third quarter 2023 financial results on November 1, 2023, after the market closes. The company will host a conference call at 5:00 PM EDT on the same day to discuss the results, business highlights, and outlook. This event will provide stakeholders and investors with insights into the company’s performance and strategy moving forward.
Read more →LMATLeMaitre to Present at the 2023 Cantor Global Healthcare Conference
LeMaitre Vascular, Inc. announced that its President, David Roberts, will present at the 2023 Cantor Global Healthcare Conference on September 26, 2023. This event will take place in New York City and underscores LeMaitre's dedication to public engagement regarding its products for peripheral vascular disease. The company provides vital devices and services that cater to the needs of vascular surgeons globally.
Read more →LMATLeMaitre Q2 2023 Financial Results
LeMaitre Vascular, Inc. reported its Q2 2023 financial results, showcasing a 19% increase in sales year-over-year, reaching $50.1 million. The company also witnessed a substantial net income growth of 130%, reflective of increased hospital procedures and selling price adjustments. Despite these successes, the gross margin saw a decline to 64.0% due to manufacturing inefficiencies. For the upcoming quarters, management provided optimistic sales and earnings guidance, alongside the approval of a quarterly dividend.
Read more →LMATLeMaitre to Present at Upcoming Investor Conferences in August
LeMaitre Vascular, Inc. is set to participate in two investor conferences in August 2023, showcasing its commitment to stakeholder engagement. CFO JJ Pellegrino will attend the Needham Virtual MedTech & Diagnostics 1x1 Conference, while President David Roberts will present at the UBS MedTech, Tools and Genomics Summit. This engagement underscores the company's positioning as a key player in the vascular device industry, addressing peripheral vascular diseases affecting millions globally.
Read more →LMATLeMaitre Will Announce Second Quarter 2023 Earnings Results August 1, 2023
LeMaitre Vascular, Inc. has announced it will report its second quarter financial results on August 1, 2023, after market close. A conference call is scheduled for the same day at 5:00 PM ET to discuss the results, along with business highlights and company outlook. This highlights the company's ongoing engagement with its stakeholders and commitment to operational transparency.
Read more →LMATLeMaitre to Present at Upcoming Investor Conferences in June
LeMaitre Vascular, Inc. announced its participation in two investor conferences slated for June. The company's CFO, JJ Pellegrino, will present at the Jefferies Healthcare Conference, while President David Roberts will speak at the Sidoti Small Cap Virtual Conference. These presentations are expected to boost LeMaitre's engagement with the investment community and highlight its offerings in peripheral vascular disease treatment.
Read more →LMATLeMaitre Q1 2023 Financial Results
LeMaitre (Nasdaq:LMAT) reported strong Q1 2023 financial results with sales of $47.1 million, representing a 19% increase from the previous year. The company declared a quarterly dividend of $0.14 per share and highlighted an anticipated 15% growth in sales for Q2 2023 due to increasing hospital staffing and pricing. However, operating income dropped by 1% amid rising operating expenses. Additionally, LeMaitre announced a three-year distribution agreement for Aziyo's cardiac patches, potentially enhancing future sales prospects.
Read more →LMATLeMaitre to Distribute Aziyo Biologics’ Cardiovascular Patches
LeMaitre Vascular, Inc. has announced an agreement to exclusively distribute Aziyo Biologics' cardiovascular patches in the U.S. for three years, with an option to acquire Aziyo's global business during this period. The patches, designed to reduce inflammation and promote healthy tissue, generated $6.8 million in sales for Aziyo in 2022. LeMaitre anticipates a 50% gross margin on these products, diversifying its offerings for vascular and cardiac surgeons. Further details on the financial impact will be discussed in the upcoming Q1 earnings call.
Read more →LMATLeMaitre Will Announce First Quarter 2023 Earnings Results May 2, 2023
LeMaitre Vascular, Inc. has announced that it will release its first quarter 2023 financial results on May 2, 2023, after market close. A conference call is set for the same day at 5:00 PM ET to discuss the results, business highlights, and future outlook. LeMaitre specializes in devices and services for treating peripheral vascular disease, catering to a vast market of over 200 million affected individuals worldwide.
Read more →LMATLeMaitre to Go Direct in Thailand
LeMaitre Vascular, Inc. announced its agreement to acquire its Thai distributor, Prompt Serve, for $688,000. This acquisition marks LeMaitre's continued expansion efforts in the Asia-Pacific region, with plans to sell directly to Thai hospitals by the second half of 2023. This will be the company's 29th direct-to-hospital market and follows similar efforts in Korea. LeMaitre aims to boost its market share and expects to reveal more on how this transaction will affect its 2023 financial guidance during the upcoming earnings call.
Read more →LMATLeMaitre Q4 2022 Financial Results
LeMaitre Vascular, Inc. reported its Q4 2022 financial results, reflecting a 4% increase in total sales compared to the same quarter in 2021, alongside an organic growth rate of 8%. The company announced a $0.14 quarterly dividend, which is a 12% increase. While certain segments like carotid shunts and bovine grafts showed significant growth, both operating and net incomes fell by 16% and 9%, respectively. For Q1 2023, LeMaitre forecasts a modest sales increase and forecasts a decrease in earnings per share from the previous quarter.
Read more →LMATLeMaitre Will Announce Fourth Quarter 2022 Earnings Results February 23, 2023
LeMaitre Vascular, Inc. has announced it will release its fourth quarter 2022 financial results on February 23, 2023, after market close. A conference call is scheduled for the same day at 5:00 PM ET to discuss the results, business highlights, and outlook. This initiative reflects the company's dedication to keeping investors informed about its performance.
Read more →LMATLeMaitre to Present at Upcoming Investor Conferences
BURLINGTON, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two upcoming investor conferences. David Roberts, President, will present at the Piper Sandler 34th Annual Healthcare Conference on Wednesday, N
Read more →LMATLeMaitre Q3 2022 Financial Results
BURLINGTON, Mass., Oct. 27, 2022 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q3 2022 results, announced a $0.125/share quarterly dividend and provided guidance. Q3 2022 Financial Results Sales of $39.0mm, +2%
Read more →LMATLeMaitre Will Announce Third Quarter 2022 Earnings Results October 27, 2022
BURLINGTON, Mass., Oct. 17, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2022 financial results on Thursday, October 27, 2022, after the market close. The company has scheduled a conference call for 5:00 PM
Read more →LMATLeMaitre to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
BURLINGTON, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference on Wednesday, September 14, 2022, at 4:40 P
Read more →LMATLeMaitre to Present at the Canaccord Genuity 42nd Annual Growth Conference
BURLINGTON, Mass., Aug. 01, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the Canaccord Genuity 42nd Annual Growth Conference on Thursday, August 11, 2022, at 12:00 PM ET at the InterCon
Read more →LMATLeMaitre Q2 2022 Financial Results
BURLINGTON, Mass., July 28, 2022 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2022 results, announced a $0.125/share quarterly dividend and provided guidance. Q2 2022 Financial Results Sales of $42.1mm, +4%
Read more →LMATLeMaitre Will Announce Second Quarter 2022 Earnings Results July 28, 2022
BURLINGTON, Mass., July 18, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2022 financial results on Thursday, July 28, 2022, after the market close. The company has scheduled a conference call for 5:00 PM ET
Read more →LMATLeMaitre to Present at the Sidoti Summer Small Cap Virtual Conference
BURLINGTON, Mass., June 03, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the Sidoti Summer Small Cap Virtual Conference on Wednesday, June 15, 2022, at 2:30 PM ET. LeMaitre is a provider of devices,
Read more →LMATLeMaitre Q1 2022 Financial Results
BURLINGTON, Mass., April 28, 2022 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2022 results, announced a $0.125/share quarterly dividend and provided guidance. Q1 2022 Financial Results Sales of $39.6mm, +1
Read more →LMATLeMaitre Will Announce First Quarter 2022 Earnings Results April 28, 2022
BURLINGTON, Mass., April 15, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2022 financial results on Thursday, April 28, 2022, after the market close. The company has scheduled a conference call for 5:00 PM E
Read more →LMATLeMaitre to Present at the Needham Virtual Healthcare Conference
BURLINGTON, Mass., April 01, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the 21st Annual Needham Virtual Healthcare Conference on Thursday, April 14, 2022, at 10:15 AM ET. LeMaitre is
Read more →LMATLeMaitre Joins NASDAQ Dividend Achievers Index – 10 Years of Dividend Increases
BURLINGTON, Mass., March 21, 2022 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today announced that it has joined the NASDAQ US Broad Dividend Achievers Index. The index is comprised of US securities with at least ten consecut
Read more →LMATLeMaitre Q4 2021 Financial Results
BURLINGTON, Mass., Feb. 24, 2022 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2021 results, announced a $0.125/share quarterly dividend (+14%) and provided guidance. Q4 2021 Financial Results Sales of $39.5
Read more →LMATLeMaitre Will Announce Fourth Quarter 2021 Earnings Results February 24, 2022
BURLINGTON, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2021 financial results on Thursday, February 24, 2022, after the market close. The company has scheduled a conference call for 5:00 P
Read more →LMATLeMaitre to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
BURLINGTON, Mass., Feb. 09, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Wednesday, February 16, 2022, at
Read more →LMATLeMaitre to Present at the Needham Virtual Growth Conference
BURLINGTON, Mass., Dec. 30, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the 24th Annual Needham Virtual Growth Conference on Friday, January 14, 2022, at 3:30 PM. LeMaitre is a provid
Read more →LMATLeMaitre to Participate at Upcoming Investor Conferences
BURLINGTON, Mass., Nov. 02, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming virtual investor conferences. Stifel 2021 Virtual Healthcare Conference Monday, November 15, 2021 David Roberts, P
Read more →LMATLeMaitre Q3 2021 Financial Results
BURLINGTON, Mass., Oct. 28, 2021 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q3 2021 results, announced an $0.11/share quarterly dividend and provided guidance. Q3 2021 Financial Results Sales of $38.4mm, +5%
Read more →LMATLeMaitre Will Announce Third Quarter 2021 Earnings Results on October 28, 2021
BURLINGTON, Mass., Oct. 14, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2021 financial results on Thursday, October 28, 2021, after the market close. The company has scheduled a conference call for 5:00 PM
Read more →LMATLeMaitre Vascular to Participate at Upcoming Investor Conferences in September
BURLINGTON, Mass., Sept. 01, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in four virtual investor conferences in September. Barrington Research 14th Annual Virtual Fall Investment Conference Thursday, Sept
Read more →LMATLeMaitre Q2 2021 Financial Results
BURLINGTON, Mass., July 29, 2021 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2021 results, announced an $0.11/share quarterly dividend and provided guidance. Q2 2021 Financial Results Sales of $40.7mm, +64
Read more →LMATLeMaitre Will Announce Second Quarter 2021 Earnings Results on July 29, 2021
BURLINGTON, Mass., July 15, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2021 financial results on Thursday, July 29, 2021, after the market close. The company has scheduled a conference call for 5:00 PM ET
Read more →LMAT▼ -9.2%on this newsshared move
LeMaitre Announces Pricing of Public Offering of Common Stock
BURLINGTON, Mass., July 13, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices, implants and services, today announced the pricing of an underwritten public offering of 1,000,000 shares of its common stock at a public offerin
Read more →LMATLeMaitre Vascular Announces Proposed Public Offering of Common Stock
BURLINGTON, Mass., July 13, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices, implants and services, today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares to
Read more →LMATLeMaitre Provides Q2 2021 Update
BURLINGTON, Mass., July 13, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices, implants and services, today announced preliminary unaudited results for the quarter ended June 30, 2021. Q2 2021 Preliminary Results Net Sales
Read more →LMATLeMaitre to Present at the Goldman Sachs Virtual Global Healthcare Conference
BURLINGTON, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the Goldman Sachs 42nd Annual Virtual Global Healthcare Conference on Thursday, June 10, 2021, at 5:30 PM ET. LeMaitre is a p
Read more →LMATLeMaitre Regains Five CE Marks
BURLINGTON, Mass., May 25, 2021 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today announced that it received CE marks under the European Medical Devices Directive (93/42/EC as amended by 2007/47/EC) for the following five pro
Read more →LMATLeMaitre to Present at the Jefferies Virtual Healthcare Conference
BURLINGTON, Mass., May 20, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the Jefferies Virtual Healthcare Conference on Friday, June 4, 2021, at 1:30 PM EDT. LeMaitre is a provider of d
Read more →LMATLeMaitre Q1 2021 Financial Results
BURLINGTON, Mass., April 29, 2021 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2021 results and announced an $0.11/share quarterly dividend. Sales of $35.9mm, +17% (-5% organic) vs. Q1 2020 Op. income of $7
Read more →LMATLeMaitre Will Announce First Quarter 2021 Earnings Results on April 29, 2021
BURLINGTON, Mass., April 14, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2021 financial results on Thursday, April 29, 2021, after the market close. The company has scheduled a conference call for 5:00 PM E
Read more →LMATLeMaitre Q4 2020 Financial Results
BURLINGTON, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2020 results and announced an $0.11/share quarterly dividend. Sales of $37.5mm, +24% (+3% organic) vs. Q4 2019 Op. income of $9.
Read more →LMATLeMaitre Vascular to Present at Upcoming Investor Conferences
BURLINGTON, Mass., Feb. 16, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in four upcoming investor conferences. David Roberts, President, is scheduled to present at the following virtual conferences: SVB Leerink's 10th
Read more →LMATLeMaitre Vascular Will Announce Fourth Quarter 2020 Earnings Results on February 25, 2021
BURLINGTON, Mass., Jan. 27, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2020 financial results on Thursday, February 25, 2021, after the market close. The company has scheduled a conference call for 5:00 P
Read more →LMATLeMaitre Vascular to Present at the Jefferies Virtual London Healthcare Conference
BURLINGTON, Mass., Nov. 11, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at Jefferies Virtual London Healthcare Conference on Wednesday, November 18, 2020, at 12:25 PM ET. LeMaitre Vascular is a provid
Read more →LMATLeMaitre Vascular Announces Q3 2020 Financial Results
BURLINGTON, Mass., Oct. 29, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q3 2020 results and announced a $0.095/share quarterly dividend. Sales of $36.4mm, +25% (-3% organic) vs. Q3 2019 Op
Read more →LMATLeMaitre Vascular Will Announce Third Quarter 2020 Earnings Results on October 29, 2020
BURLINGTON, Mass., Oct. 09, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2020 financial results on Thursday, October 29, 2020, after the market close. The company has scheduled a conference call for 5:00 PM
Read more →LMATLeMaitre Vascular Announces Q2 2020 Financial Results
BURLINGTON, Mass., July 23, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2020 results and announced a $0.095/share quarterly dividend. Sales of $24.9mm, -16% (-24% organic) vs. Q2 2019 O
Read more →LMATLeMaitre Vascular Will Announce Second Quarter 2020 Earnings Results on July 23, 2020
BURLINGTON, Mass., July 10, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2020 financial results on Thursday, July 23, 2020, after the market close. The company has scheduled a conference call for 5:00 PM ED
Read more →LMATLeMaitre Vascular Acquires Artegraft
BURLINGTON, Mass., June 22, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced that it has acquired the business and assets of Artegraft, Inc. for $90.0 million, including $72.5 million in cash paid at closing ($65.0 million to Artegraft plus $7.5 in escrow
Read more →LMATLeMaitre Vascular to Present at the Jefferies Virtual Healthcare Conference
BURLINGTON, Mass., May 28, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the Jefferies Virtual Healthcare Conference on Thursday, June 4, 2020, at 2:00 PM EDT. LeMaitre Vascular is a pr
Read more →LMATLeMaitre Vascular to Present at the UBS Virtual Global Healthcare Conference
BURLINGTON, Mass., May 12, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the UBS Virtual Global Healthcare Conference on Wednesday, May 20, 2020, at 8:20 AM EDT. LeMaitre Vascular is a provider of de
Read more →LMATLeMaitre Vascular Announces Q1 2020 Financial Results
BURLINGTON, Mass., April 30, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2020 results and announced a $0.095/share quarterly dividend. Record sales of $30.6mm, +7% (-1% organic) vs. Q1 2
Read more →LMATLeMaitre Vascular Withdraws Prior Annual Guidance for 2020 And Announces Preliminary Q1 2020 Financial Results
BURLINGTON, Mass., April 13, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, announced today Q1 2020 preliminary, unaudited results and withdrew prior annual guidance for 2020 due to the potential impact of CO
Read more →LMATLeMaitre Vascular to Present at the SVB Leerink Global Healthcare Conference on Tuesday, February 25, 2020
BURLINGTON, Mass., Feb. 18, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the 9th Annual SVB Leerink Global Healthcare Conference on Tuesday, February 25, 2020 at the Lotte New York Palace Hotel in Ne
Read more →LMATLeMaitre Vascular Announces Q4 2019 Financial Results
BURLINGTON, Mass., Feb. 06, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2019 results, provided guidance, and announced a $0.095/share dividend. Record sales of $30.2mm, +6% (flat organic
Read more →LMATLeMaitre Vascular Will Announce Fourth Quarter 2019 Earnings Results on February 6, 2020
BURLINGTON, Mass., Jan. 29, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2019 financial results on Thursday, February 6, 2020, after the market close. The company has scheduled a conference call for 5:00 PM
Read more →LMATLeMaitre Vascular to Present at the Needham Growth Conference on Wednesday, January 15, 2020
BURLINGTON, Mass., Jan. 03, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the 22nd Annual Needham Growth Conference on Wednesday, January 15, 2020 at the Lotte New York Palace Hotel in N
Read more →LMATLeMaitre Vascular Announces Q3 2019 Financial Results
BURLINGTON, Mass., Oct. 23, 2019 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q3 2019 results, provided guidance, and announced an $0.085/share dividend. Sales of $29.1mm, +20% (+13% organic) vs.
Read more →LMATLeMaitre Vascular Acquires Biologic Patch Business from Admedus
BURLINGTON, Mass., Oct. 13, 2019 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), announced that it has acquired the biologic patch business of Admedus Ltd (ASX: AHZ) for $15.5 million, of which $14.2 million was paid at closing and $1.3 million is due in two post-clos
Read more →LMATLeMaitre Vascular Will Announce Third Quarter 2019 Earnings Results on October 23, 2019
BURLINGTON, Mass., Oct. 11, 2019 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2019 financial results on Wednesday, October 23, 2019, after the market close. The company has scheduled a conference call for 5:00 PM
Read more →LMATLeMaitre Vascular to Present at the Canaccord Genuity Annual Growth Conference on Thursday, August 8, 2019
BURLINGTON, Mass., July 30, 2019 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the Canaccord Genuity 39th Annual Growth Conference on Thursday, August 8, 2019 at the InterContinental Hotel in
Read more →LMATLeMaitre Vascular Announces Q2 2019 Financial Results
BURLINGTON, Mass., July 24, 2019 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2019 results, provided guidance, and announced a $0.085/share dividend. Record sales of $29.5mm, +9% (+5% organic)
Read more →LMATLeMaitre Vascular Will Announce Second Quarter 2019 Earnings Results on July 24, 2019
BURLINGTON, Mass., July 11, 2019 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2019 financial results on Wednesday, July 24, 2019, after the market close. The company has scheduled a conference call for 5:00 PM E
Read more →LMATLeMaitre Vascular to Present at the Jefferies Healthcare Conference on Thursday, June 6, 2019
BURLINGTON, Mass., May 29, 2019 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the Jefferies Healthcare Conference on Thursday, June 6, 2019 at the Grand Hyatt Hotel in New York City. The Com
Read more →LMATLeMaitre Vascular Announces Q1 2019 Financial Results
BURLINGTON, Mass., May 01, 2019 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2019 results, provided guidance, and announced a $0.085/share dividend. Record sales of $28.5mm, +10% (+7% organic)
Read more →LMATLeMaitre Vascular Will Announce First Quarter 2019 Earnings Results on May 1, 2019
BURLINGTON, Mass., April 24, 2019 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2019 financial results on Wednesday, May 1, 2019, after the market close. The company has scheduled a conference call for 5:00 PM EDT
Read more →LMATLeMaitre Vascular Announces Q4 2018 Financial Results
BURLINGTON, Mass., Feb. 19, 2019 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2018 results, provided guidance, announced a 21% dividend increase to $0.085/share and announced a share repurchase
Read more →LMATLeMaitre Vascular Will Announce Fourth Quarter 2018 Earnings Results on February 19, 2019
BURLINGTON, Mass., Feb. 06, 2019 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2018 financial results on Tuesday, February 19, 2019, after the market close. The company has scheduled a conference call for 5:00 PM
Read more →LMATLeMaitre Vascular to Present at the Needham Growth Conference on Wednesday, January 16, 2019
BURLINGTON, Mass., Jan. 08, 2019 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at Needham Growth Conference on Wednesday, January 16, 2019 at the Lotte New York Palace Hotel in New York, NY. Th
Read more →LMATLeMaitre Vascular Acquires Cardial Business of BD
BURLINGTON, Mass., Oct. 24, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), announced today that it has acquired the assets of Cardial, a subsidiary of BD (Becton, Dickinson & Company), located in Saint-Étienne, France. The total purchase price for the acquired as
Read more →LMATLeMaitre Vascular Announces Preliminary Q3 2018 Results BURLINGTON, MA
LeMaitre Vascular Announces Preliminary Q3 2018 Results BURLINGTON, MA, October 4, 2018 - LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, announced today Q3 2018 preliminary unaudited results, provided Q4 2018 and updated full year
Read more →LMATLeMaitre Vascular Acquires Clot Management Business from Applied Medical
LeMaitre Vascular Acquires Clot Management Business from Applied Medical BURLINGTON, Mass., September 26, 2018 (GLOBE NEWSWIRE) LeMaitre Vascular, Inc. (Nasdaq:LMAT), announced today that it has acquired the vascular clot management business of Applied Medical Resources Corpora
Read more →LMATLeMaitre Q2 2018 Record Sales $27.0mm (+5%), Record EPS $0.43 (+86%) BURLINGTON, MA
LeMaitre Q2 2018 Record Sales $27.0mm (+5%), Record EPS $0.43 (+86%) BURLINGTON, MA, July 26, 2018 - LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2018 results, provided guidance and announced a $0.07/share divid
Read more →LMATLeMaitre Vascular Will Announce Second Quarter 2018 Earnings Results on July 26, 2018
BURLINGTON, Mass., July 18, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2018 financial results on Thursday, July 26, 2018, after the market close. The company has scheduled a conference call for 5:00 PM ED
Read more →LMATLeMaitre Vascular to Present at the Jefferies Healthcare Conference on Friday, June 8, 2018
BURLINGTON, Mass., June 01, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the Jefferies Healthcare Conference on Friday, June 8, 2018 at the Grand Hyatt Hotel in New York, NY. The Compa
Read more →LMATLeMaitre Q1 2018 Sales $26.0mm (+8%), EPS $0.19 (+17%) BURLINGTON, MA
LeMaitre Q1 2018 Sales $26.0mm (+8%), EPS $0.19 (+17%) BURLINGTON, MA, April 25, 2018 - LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2018 results, provided guidance, and announced a $0.07/share dividend. Q1 201
Read more →LMATLeMaitre Q1 2018 Sales $26.0mm (+8%), EPS $0.19 (+17%)
BURLINGTON, Mass., April 25, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2018 results, provided guidance, and announced a $0.07/share dividend. Sales of $26.0mm, +8% vs. Q1 2017 Operati
Read more →LMATLeMaitre Vascular Will Announce First Quarter 2018 Earnings Results on April 25, 2018
BURLINGTON, Mass., April 18, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2018 financial results on Wednesday, April 25, 2018, after the market close. The company has scheduled a conference call for 5:00 PM
Read more →LMATLeMaitre Vascular Divests General Surgery Product Lines
LeMaitre Vascular Divests General Surgery Product Lines BURLINGTON, Mass., April 5, 2018 (GLOBE NEWSWIRE) LeMaitre Vascular, Inc. (Nasdaq:LMAT), announced today that it has divested its general surgery product lines to Symmetry Surgical, Inc. for $7.4 million. Included in the
Read more →LMATLeMaitre Q4 2017 Record Sales $26.2mm (+12%), Record Op. Income $6.3mm (+62%) BURLINGTON, MA
LeMaitre Q4 2017 Record Sales $26.2mm (+12%), Record Op. Income $6.3mm (+62%) BURLINGTON, MA, February 21, 2018 - LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2017 results, provided guidance, and announced a 27%
Read more →LMATLeMaitre Vascular Will Announce Fourth Quarter 2017 Earnings Results on February 21, 2018
BURLINGTON, Mass., Feb. 09, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2017 financial results on Wednesday, February 21, 2018, after the market close. The company has scheduled a conference call for 5:00
Read more →LMATLeMaitre Vascular to Present at the Needham Growth Conference on Thursday, January 18, 2018
BURLINGTON, Mass., Jan. 11, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at Needham & Company’s 20th Annual Growth Conference on Thursday, January 18, 2018 at the Lotte New York Palace Hot
Read more →LMATLeMaitre Vascular to Present at Upcoming November and December Investor Conferences
BURLINGTON, Mass., Nov. 01, 2017 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in six investor conferences in November and December. JJ Pellegrino, Chief Financial Officer, is scheduled to present at the Canaccord Medical
Read more →LMATLeMaitre Q3 2017 Sales $24.8mm (+7%), Record EPS $0.25 (+49%) BURLINGTON, MA
LeMaitre Q3 2017 Sales $24.8mm (+7%), Record EPS $0.25 (+49%) BURLINGTON, MA, October 26, 2017 - LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q3 2017 results, provided guidance, and announced a $0.055/share dividen
Read more →LMATLeMaitre Vascular Will Announce Third Quarter 2017 Earnings Results on October 26, 2017
BURLINGTON, Mass., Oct. 16, 2017 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2017 financial results on Thursday, October 26, 2017, after the market close. The company has scheduled a conference call for 5:00 PM
Read more →LMATLeMaitre Q2 2017 Record Sales $25.8 mm (+15%), Record EPS $0.23 (+69%) BURLINGTON, MA
LeMaitre Q2 2017 Record Sales $25.8 mm (+15%), Record EPS $0.23 (+69%) BURLINGTON, MA, July 27, 2017 - LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2017 results, provided increased guidance, announced a $0.055/s
Read more →LMATLeMaitre Vascular Will Announce Second Quarter 2017 Earnings Results on July 27, 2017
BURLINGTON, Mass., July 13, 2017 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2017 financial results on Thursday, July 27, 2017, after the market close. The company has scheduled a conference call for 5:00 PM ED
Read more →LMATLeMaitre Q1 2017 Record Sales $24.1 mm (+19%), Net Income $3.2 mm (+49%) BURLINGTON, MA
LeMaitre Q1 2017 Record Sales $24.1 mm (+19%), Net Income $3.2 mm (+49%) BURLINGTON, MA, April 26, 2017 - LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2017 results, provided guidance, and announced a $0.055/shar
Read more →LMATLeMaitre Vascular Will Announce First Quarter 2017 Earnings Results on April 26, 2017
BURLINGTON, Mass., April 12, 2017 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2017 financial results on Wednesday, April 26, 2017, after the market close. The company has scheduled a conference call for 5:00 PM
Read more →LMATLeMaitre Vascular to Present at the 16th Annual Needham Healthcare Conference on Tuesday, April 4, 2017
BURLINGTON, Mass., March 31, 2017 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at 16th Annual Needham Healthcare Conference on Tuesday, April 4, 2017 at The Westin Grand Central, New York City, NY. The Comp
Read more →LMATLeMaitre Vascular to Present at the Sidoti & Company Spring 2017 Convention on Wednesday, March 29, 2017
BURLINGTON, Mass., March 23, 2017 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at Sidoti & Company Spring 2017 Convention on Wednesday, March 29, 2017 at the Marriott Marquis, New York City, NY
Read more →LMATLeMaitre Vascular to Present at the Barclays Global Healthcare Conference on Tuesday, March 14, 2017
BURLINGTON, Mass., March 09, 2017 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at Barclays Global Healthcare Conference on Tuesday, March 14, 2017 at the Loews Miami Beach Hotel in Miami Beach, FL. The Comp
Read more →LMATLeMaitre Vascular to Present at the 29th Annual ROTH Conference on Tuesday, March 14, 2017
BURLINGTON, Mass., March 08, 2017 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that George W. LeMaitre, Chairman & CEO, will present at 29th Annual ROTH Conference on Tuesday, March 14, 2017 at the Ritz-Carlton, Laguna Niguel, CA. The Company is sche
Read more →LMATLeMaitre Vascular to Present at the Cowen & Company 37th Annual Health Care Conference on March 6, 2017
BURLINGTON, Mass., March 01, 2017 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the Cowen & Company Annual Health Care Conference on Monday, March 6, 2017 at the Marriott Copley Place in Bost
Read more →LMATLeMaitre Vascular to Participate in 2017 BTIG Medical Technology, Life Science and Diagnostic Tools Conference on Wednesday, March 1, 2017
BURLINGTON, Mass., Feb. 23, 2017 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will participate in BTIG’s 2017 Medical Technology, Life Science and Diagnostic Tools Conference on Wednesday, March 1, 2017 in
Read more →LMATLeMaitre Q4 2016 Record Sales $23.3 mm (+14%), Op. Income $3.9 mm (+27%) BURLINGTON, MA
LeMaitre Q4 2016 Record Sales $23.3 mm (+14%), Op. Income $3.9 mm (+27%) BURLINGTON, MA, February 21, 2017 - LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2016 results, provided guidance, and announced a 22% divi
Read more →LMATLeMaitre Vascular Will Announce Fourth Quarter 2016 Earnings Results on February 21, 2017
BURLINGTON, Mass., Feb. 07, 2017 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2016 financial results on Tuesday, February 21, 2017, after the market close. The company has scheduled a conference call for 5:00 PM
Read more →LMATLeMaitre Vascular to Present at the Needham Growth Conference on Thursday, January 12, 2017
BURLINGTON, Mass., Jan. 05, 2017 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at Needham & Company’s 19th Annual Growth Conference on Thursday, January 12, 2017 at the Lotte New York Palace Hot
Read more →LMATLeMaitre Vascular to Participate in the Guggenheim Securities 4th Annual Boston Healthcare Conference on Tuesday, December 13, 2016
BURLINGTON, Mass., Dec. 07, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will participate in the Guggenheim Securities 4th Annual Boston Healthcare Conference on Tuesday, December 13, 2016 at the Intercontinental Ho
Read more →LMATLeMaitre Vascular to Participate in the Benchmark Micro Cap Discovery Conference on Thursday, December 1, 2016
BURLINGTON, Mass., Nov. 29, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will participate in the Benchmark Company Micro Cap Discovery One-on-One Investor Conference on Thursday, December 1, 2016 at the Palmer House
Read more →LMATLeMaitre Vascular Acquires Restore Flow Allografts
LeMaitre Vascular Acquires Restore Flow Allografts BURLINGTON, Mass., November 10, 2016 (GLOBE NEWSWIRE) LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that it has acquired the assets of Restore Flow Allografts, LL
Read more →LMATLMAT INVESTMENT HIGHLIGHTS: $89.6mm sales in 2016* 14% reported growth 12% organic growth $16.9mm operating income in 2016* 47% growth 19% operating margin 91 direct sales reps Acquisition and R&D strategy Strong balance
LMAT INVESTMENT HIGHLIGHTS: $89.6mm sales in 2016* $16.9mm operating income in 2016* 19% operating margin 91 direct sales reps Acquisition and R&D strategy sheet, dividend payer, share repurchase *Management Guidance, November 10, 2016 +14% reported growth +12% 200720082
Read more →LMATLeMaitre Vascular to Present at Three Investor Conferences in November
BURLINGTON, Mass., Nov. 08, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in three investor conferences in November. David Roberts, President, is scheduled to present at the Stifel Healthcare Conference in New York o
Read more →LMATLeMaitre Q3 2016 Record Sales $23.2 mm (+22%), Record Op. Income $5.3 mm (+61%) BURLINGTON, MA
LeMaitre Q3 2016 Record Sales $23.2 mm (+22%), Record Op. Income $5.3 mm (+61%) BURLINGTON, MA, October 26, 2016 - LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, today reported Q3 2016 results, provided increased guidance, and announced a $0.045/share di
Read more →LMATLeMaitre Vascular to Present at the Sidoti & Company Fall 2016 Emerging Growth Convention on November 1, 2016
BURLINGTON, Mass., Oct. 25, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the Sidoti & Company Fall 2016 Emerging Growth Convention on Tuesday, November 1, 2016 at the New York Marriott
Read more →LMATLeMaitre Vascular Will Announce Third Quarter 2016 Earnings Results on October 26, 2016
BURLINGTON, Mass., Oct. 18, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2016 financial results on Wednesday, October 26, 2016, after the market close. The company has scheduled a conference call for 5:00 PM
Read more →LMATLeMaitre Vascular to Participate in the Dougherty & Co. Institutional Investor Conference on September 28, 2016
BURLINGTON, Mass., Sept. 20, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will participate in the 2016 Dougherty & Co. Institutional Investor Conference on Wednesday, September 28, 2016 at the Millenni
Read more →LMATLeMaitre Vascular to Attend the 9th Annual Barrington Research Fall Investment Conference on September 8, 2016
BURLINGTON, Mass., Aug. 25, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the 9th Annual Barrington Research Fall Investment Conference on Thursday, September 8, 2016 at the Four Seasons
Read more →LMATLeMaitre Vascular to Participate in the Midwest IDEAS Investor Conference on August 30, 2016
BURLINGTON, Mass., Aug. 16, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that George W. LeMaitre, Chairman & CEO, will present at the Midwest IDEAS Investor Conference on Tuesday, August 30, 2016 at the Hard Rock Hotel in Chicago, IL. The Compan
Read more →LMATLeMaitre Vascular to Participate in the Canaccord Genuity 36th Annual Growth Conference on August 11, 2016
BURLINGTON, Mass., Aug. 02, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that J.J. Pellegrino, Chief Financial Officer, will present at the Canaccord Genuity 36th Annual Growth Conference on Thursday, August 11, 2016 at the Intercontinental Hotel
Read more →LMATLeMaitre Q2 2016 Record Sales $22.4mm (+13%), Record Op. Income $3.8mm (+35%) $5.0mm Share Repurchase BURLINGTON, MA
LeMaitre Q2 2016 Record Sales $22.4mm (+13%), Record Op. Income $3.8mm (+35%) $5.0mm Share Repurchase BURLINGTON, MA, July 27, 2016 - LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, today reported Q2 2016 results, provided increased guidance, announced a
Read more →LMATLeMaitre Vascular Will Announce Second Quarter 2016 Earnings Results on July 27, 2016
BURLINGTON, Mass., July 19, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2016 financial results on Wednesday, July 27, 2016, after the market close. The company has scheduled a conference call for 5:00 PM E
Read more →LMATLeMaitre Vascular to Present at the East Coast IDEAS Investor Conference on June 28, 2016
BURLINGTON, Mass., June 16, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President will present at the East Coast IDEAS Investor Conference on Tuesday, June 28, 2016 at the Boston Park Plaza in Boston, MA. The Company's prese
Read more →LMATLeMaitre Vascular to Participate in the Benchmark One-on-One Conference on June 2, 2016
BURLINGTON, Mass., May 18, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will participate in the Benchmark Company, LLC, One-on-One Investor Conference on Thursday, June 2, 2016 at the Pfister Hotel in Milwaukee, WI.
Read more →LMATLeMaitre Q1 2016 Sales $20.3mm (+7%), Op. Inc. $3.3mm (+43%) BURLINGTON, MA
LeMaitre Q1 2016 Sales $20.3mm (+7%), Op. Inc. $3.3mm (+43%) BURLINGTON, MA, May 2, 2016 - LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, today reported Q1 2016 results, announced a $0.045/share dividend and provided guidance. Q1 2016 results included:
Read more →LMATLeMaitre Q1 2016 Sales $20.3mm (+7%), Op. Inc. $3.3mm (+43%)
BURLINGTON, Mass., May 02, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, today reported Q1 2016 results, announced a $0.045/share dividend and provided guidance. Q1 2016 results included: Sales of $20.3mm, +7% vs. Q1 2015 Gross
Read more →LMATLeMaitre Vascular Will Announce First Quarter 2016 Earnings Results on May 2, 2016
BURLINGTON, Mass., April 19, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2016 financial results on Monday, May 2, 2016, after the market close. The company has scheduled a conference call for 5:00 PM EDT th
Read more →LMATLeMaitre Vascular to Participate in the Needham & Company 15th Annual Health Care Conference on April 12, 2016
BURLINGTON, Mass., April 04, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the Needham and Company 15th Annual Health Care Conference on Tuesday, April 12, 2016 at the Westin Grand Central Hotel in Ne
Read more →LMATLeMaitre Vascular Acquires ProCol Vascular Bioprosthesis
BURLINGTON, Mass., March 18, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that it has acquired the ProCol Vascular Bioprosthesis product line from Hancock Jaffe Laboratories, Inc. for $665,
Read more →LMATLeMaitre Vascular to Participate in the Cowen and Company 36th Annual Health Care Conference on March 9, 2016
BURLINGTON, Mass., March 04, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the Cowen and Company 36th Annual Health Care Conference on Wednesday, March 9, 2016 at the Marriott Copley Place in Boston,
Read more →LMATLeMaitre Vascular to Participate in Two Investor Conferences in March
BURLINGTON, Mass., March 01, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in two investor conferences in March. David Roberts, President, is scheduled to present at the 28th Annual ROTH Conference at the Ritz-Carlto
Read more →LMATLeMaitre Q4 2015 Record Sales $20.5mm (+14% organic), Record Net Income $2.5mm (+32%)
BURLINGTON, Mass., Feb. 24, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, today reported Q4 2015 results, announced an increased dividend of $0.045/share and provided guidance. Q4 2015 results included: Record sales of $20.5mm,
Read more →LMATLeMaitre Vascular to Participate in BTIG MedTech Conference February 24-26, 2016
BURLINGTON, Mass., Feb. 19, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, CFO, will participate in BTIG’s annual Medical Technology, Diagnostics, and Healthcare IT Conference from February 24-26, 2016 in Snowbird, Utah. For mo
Read more →LMATLeMaitre Vascular Will Announce Fourth Quarter 2015 Earnings Results on February 24, 2016
BURLINGTON, Mass., Feb. 11, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2015 financial results on Wednesday, February 24, 2016, after the market close. The company has scheduled a conference call for 5:00
Read more →LMATLeMaitre Vascular Announces Details for Its December 3rd Investor and Analyst Day
BURLINGTON, Mass., Nov. 30, 2015 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that it will webcast its investor and analyst day to be held on December 3, 2015 at Ruth’s Chris Steakhouse in New Y
Read more →LMATLeMaitre Vascular to Present at Four Investor Conferences in November
BURLINGTON, Mass., Nov. 04, 2015 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in four investor conferences in November. George W. LeMaitre, Chairman & CEO, is scheduled to present at the Brean Capital Life Sciences Summi
Read more →LMATLeMaitre Q3 2015 Sales $19.0mm (+12% organic), Record Op. Inc. $3.3mm (+79%)
BURLINGTON, Mass., Oct. 27, 2015 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, today reported Q3 2015 results, announced a $0.04/share dividend and provided guidance. Q3 2015 results included: Sales of $19.0mm, +9% reported (+12% org
Read more →LMATLeMaitre Vascular Announces Registration of TRIVEX(R) System in China
BURLINGTON, Mass., Oct. 16, 2015 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that China’s Food and Drug Administration has approved the registration of the Company’s TRIVEX System. The registration triggers a previously signed five-year, $7.8 million
Read more →LMATLeMaitre Vascular Will Announce Third Quarter 2015 Earnings Results on October 27, 2015
BURLINGTON, Mass., Oct. 14, 2015 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2015 financial results on Tuesday, October 27, 2015, after the market close. The company has scheduled a conference call for 5:00 PM E
Read more →LMATLeMaitre Vascular Hires Michael Wijas Vice President of Sales for the Americas
BURLINGTON, Mass., Sept. 09, 2015 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced that Michael Wijas has joined the Company as Vice President of Sales for the Americas. “Mike brings a depth of experience as we continue to build our sales force and add product
Read more →LMATLeMaitre Vascular to Participate in Two Investor Conferences in September
BURLINGTON, Mass., Aug. 25, 2015 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in two investor conferences in September. JJ Pellegrino, CFO, will participate in the 8th Annual Barrington Research Fall Investment Conferenc
Read more →LMATLeMaitre Q2 2015 Record Sales $19.9mm (+12% organic), Record Op. Inc. $2.8mm (+41%)
BURLINGTON, Mass., July 28, 2015 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, today reported Q2 2015 results, announced a $0.04/share dividend and provided guidance. Q2 2015 results included: Record sales of $19.9mm, +10% reported (
Read more →LMATLeMaitre Vascular to Present at Three Investor Conferences in August
BURLINGTON, Mass., July 20, 2015 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in three investor conferences in August. Beth Kurth, Investor Relations, is scheduled to present at the InvestMNt 2015 Conference in Minneapol
Read more →LMATLeMaitre Vascular Will Announce Second Quarter 2015 Earnings Results on July 28, 2015
BURLINGTON, Mass., July 15, 2015 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2015 financial results on Tuesday, July 28, 2015, after the market close. The company has scheduled a conference call for 5:00 PM ET
Read more →LMATLeMaitre Vascular Announces Analyst Day, Thursday, December 3, 2015
BURLINGTON, Mass., July 09, 2015 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced that it will host an Analyst Day on Thursday, December 3, 2015 in New York City, starting at 8:30 a.m. ET. and ending with lunch. Additional information will be released as avail
Read more →LMATLeMaitre Continues to Expand Direct-to-Hospital Sales
BURLINGTON, Mass., June 30, 2015 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), announced today that it has begun selling Direct-to-Hospital in New Zealand and will be converting Finland as of January 2016. "We continue to leverage our international presence as we tr
Read more →LMATLeMaitre Vascular Set to Join Russell 2000 Index
BURLINGTON, Mass., June 17, 2015 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is set to join the Russell 2000(R) and the Russell 3000(R) Indexes at the conclusion of the Russell indexes annual reconstitution on June 26, according to a preliminary list of additions po
Read more →LMATLeMaitre Vascular to Present on Wednesday, June 3, 2015 at the Three Part Advisors East Coast IDEAS Conference
BURLINGTON, Mass., May 28, 2015 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the Three Part Advisors East Coast IDEAS Conference Wednesday, June 3, 2015 at the Boston Park Plaza Hotel, Boston, MA. The Co
Read more →LMATLeMaitre Vascular to Present on Thursday, May 28, 2015 at the Marcum MicroCap Conference
BURLINGTON, Mass., May 14, 2015 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the 2015 Marcum MicroCap Conference on Thursday, May 28, 2015 in New York City at the Grand Hyatt Hotel. The Company's present
Read more →LMATLeMaitre Q1 2015 Record Sales $18.9mm (+13%), Op. Inc. $2.3mm
BURLINGTON, Mass., April 28, 2015 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, today reported Q1 2015 results, announced a $0.04/share dividend and provided guidance. Q1 2015 results included: Record sales of $18.9mm, +13% vs. Q1 20
Read more →LMATLeMaitre Vascular Will Announce First Quarter 2015 Earnings Results on April 28, 2015
BURLINGTON, Mass., April 20, 2015 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2015 financial results on Tuesday, April 28, 2015, after the market close. The company has scheduled a conference call for 5:00 PM ED
Read more →LMATLeMaitre Vascular to Attend the Morgan Stanley Healthcare Corporate Access Day on Wednesday, April 1, 2015
BURLINGTON, Mass., March 20, 2015 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in the Morgan Stanley Healthcare Corporate Access Day at the Langham Hotel in Boston, MA on Wednesday, April 1, 2015. JJ Pellegrino, Chief Fin
Read more →LMATLeMaitre Vascular to Present at the 27th Annual ROTH Conference on Tuesday, March 10, 2015
BURLINGTON, Mass., March 5, 2015 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in the 27th Annual ROTH Conference at the Ritz-Carlton, Laguna Niguel, CA on Tuesday, March 10, 2015. JJ Pelegrino, Chief Financial Officer, wi
Read more →LMATLeMaitre Q4 2014 Record Sales $18.7mm (+4%), Record Op. Inc. $2.7mm (+134%)
BURLINGTON, Mass., Feb. 25, 2015 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today reported Q4 2014 results. The Company increased its quarterly dividend to $0.04/share and provided guidance. Q4 2014 results
Read more →LMATLeMaitre Vascular Will Announce Fourth Quarter 2014 Earnings Results on February 25, 2015
BURLINGTON, Mass., Feb. 17, 2015 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2014 financial results on Wednesday, February 25, 2015, after the market close. The company has scheduled a conference call for 5:00
Read more →LMATLeMaitre Vascular to Attend the BTIG Medical Technology, Diagnostics, and Healthcare IT Conference on Wednesday, February 18, 2015
BURLINGTON, Mass., Feb. 13, 2015 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in the Annual BTIG Medical Technology, Diagnostics, and Healthcare IT Conference at the Cliff Lodge in Snowbird, UT on Wednesday, February 18,
Read more →LMATLeMaitre Vascular to Attend the Sidoti & Company Emerging Growth Institutional Investor Forum on Monday, January 12, 2015
BURLINGTON, Mass., Jan. 7, 2015 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in the Sidoti & Company, LLC, Emerging Growth Institutional Investor Forum at the Grand Hyatt Hotel in New York, NY on Monday, January 12, 2015.
Read more →LMATLeMaitre Vascular to Attend the Benchmark Micro Cap Discovery Conference on Thursday, December 11, 2014
BURLINGTON, Mass., Dec. 4, 2014 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in the Benchmark Company, LLC Micro Cap Discovery One-on-One Investor Conference at the Palmer House Hilton, Chicago, IL, on Thursday, December
Read more →LMATLeMaitre Vascular to Participate in Three Investor Conferences in November 2014
BURLINGTON, Mass., Nov. 12, 2014 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in three upcoming investor conferences in New York City in November. The Company will present at the Stifel 2014 Healthcare Conference at the
Read more →LMATLeMaitre Q3 2014 Sales $17.5mm (+14%) ; Op. Income $1.9mm (+139%)
BURLINGTON, Mass., Oct. 28, 2014 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) today reported Q3 2014 results, provided guidance and announced a $0.035/share dividend. Q3 2014 sales were $17.5mm, a 14% year-over-year increase driven by valvulotomes, XenoSure and Triv
Read more →LMATLeMaitre Vascular Will Announce Third Quarter 2014 Earnings Results on October 28, 2014
BURLINGTON, Mass., Oct. 21, 2014 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), announced today that it will release its third quarter 2014 financial results on October 28, 2014, after the market close. The company has scheduled a conference call for 5:00 PM EDT the s
Read more →LMATLeMaitre Vascular Acquires Angioscope
BURLINGTON, Mass., Sept. 19, 2014 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that on September 17, 2014 it acquired the angioscope product line from Applied Medical, Inc. for $420,000. Last 12
Read more →LMATLeMaitre Vascular Opens Office in Shanghai, China
BURLINGTON, Mass., Sept. 10, 2014 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that it has opened an office in Shanghai, China. To prepare for this initiative, the Company engaged its first Chin
Read more →LMATLeMaitre Vascular to Attend the Barrington Research Fall Investment Conference on September 3, 2014
BURLINGTON, Mass., Aug. 28, 2014 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the Barrington Research Fall Investment Conference at the Four Seasons Hotel in Chicago, IL. JJ Pellegrino, Chief Financial Officer, will provide an update on the Company o
Read more →LMATLeMaitre Acquires Omniflow II Biologic Graft
BURLINGTON, Mass., Aug. 18, 2014 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) acquired Xenotis, the manufacturer and marketer of the Omniflow II biological graft for peripheral bypass and dialysis access, on August 14th. Total consideration for 100% of Xenotis' share
Read more →LMATLeMaitre Vascular to Present at the Canaccord Genuity 34th Annual Growth Conference on Thursday, August 14, 2014
BURLINGTON, Mass., Aug. 12, 2014 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in the Canaccord Genuity 34th Annual Growth Conference at the InterContinental Hotel, Boston, MA, on Thursday, August 14, 2014. JJ Pelegrino, C
Read more →LMATLeMaitre Q2 2014 Record Sales $18.2mm (+14%) ; Op. Profit $2.0mm (+37%)
BURLINGTON, Mass., July 29, 2014 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) today reported Q2 2014 results, provided guidance and announced a $0.035/share dividend. Q2 2014 sales were $18.2mm, a 14% year-over-year increase, driven by Trivex (acquired Q3 2013) and
Read more →LMATLeMaitre Vascular Will Announce Second Quarter 2014 Earnings Results on July 29, 2014
BURLINGTON, Mass., July 21, 2014 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), announced today that it will release its second quarter 2014 financial results on July 29, 2014, after the market close. The company has scheduled a conference call for 5:00 PM EDT the sam
Read more →LMATLeMaitre Vascular to Present at the Wells Fargo 2014 Healthcare Conference on Tuesday, June 17, 2014
BURLINGTON, Mass., June 11, 2014 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in the Wells Fargo 2014 Healthcare Conference at the InterContinental Hotel, Boston, MA, on Tuesday, June 17, 2014. George W. LeMaitre, Chairma
Read more →LMATLeMaitre Vascular, Inc. Closes Public Offering of Common Shares
BURLINGTON, Mass., June 4, 2014 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) (the "Company"), a provider of peripheral vascular devices and implants, today announced the closing of its previously announced underwritten public offering of 1,644,500 shares of its commo
Read more →LMATLeMaitre Vascular, Inc. Priced Public Offering of Common Shares
BURLINGTON, Mass., May 30, 2014 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) (the "Company"), a provider of peripheral vascular devices and implants, today announced the pricing of an underwritten public offering of 1,430,000 shares of its common stock at a price to
Read more →LMATLeMaitre Vascular, Inc. Announces Proposed Public Offering of Common Stock
BURLINGTON, Mass., May 29, 2014 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) (the "Company"), a provider of peripheral vascular devices and implants, today announced that it has commenced an underwritten public offering of the Company's common stock. The offering is
Read more →LMATLeMaitre Q1 2014 Sales of $16.8mm (+9%)
BURLINGTON, Mass., April 29, 2014 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) today reported Q1 2014 financial results, provided Q2 2014 and full-year 2014 guidance and announced a $0.035/share dividend. Q1 2014 sales were $16.8mm, a 9% increase vs. Q1 2013. Sales
Read more →LMATLeMaitre Vascular Will Announce First Quarter 2014 Earnings Results on April 29, 2014
BURLINGTON, Mass., April 10, 2014 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), announced today that it will release its first quarter 2014 financial results on April 29, 2014, after the market close. The company has scheduled a conference call for 5:00 PM EDT the sa
Read more →LMATLeMaitre Vascular to Present at the Needham Healthcare Conference on Wednesday, April 9, 2014
BURLINGTON, Mass., April 4, 2014 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in the 13th Annual Needham Healthcare Conference at the Westin Grand Central Hotel, New York, NY, on Wednesday, April 9, 2014. David Roberts, P
Read more →LMATLeMaitre Q4 2013 Record Sales of $17.9mm (+21%)
BURLINGTON, Mass., Feb. 25, 2014 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today reported Q4 2013 and full-year 2013 financial results. The Company increased its dividend to $0.035/share and provided Q1 2014
Read more →LMATLeMaitre Vascular to Present at Three Upcoming Investor Conferences
BURLINGTON, Mass., Feb. 24, 2014 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in three upcoming investor conferences. The first is the Cowen and Company Healthcare Conference at the Boston Marriott Copley Place in Boston,
Read more →LMATLeMaitre Vascular Will Announce Fourth Quarter 2013 Earnings Results on February 25, 2014
BURLINGTON, Mass., Feb. 20, 2014 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), announced today that it will release its fourth quarter 2013 financial results on February 25, 2014, after the market close. The company has scheduled a conference call for 5:00 PM ET the
Read more →LMATLeMaitre to Sell Direct-to-Hospital in Australia and Norway
BURLINGTON, Mass., Jan. 2, 2014 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that it has begun selling Direct-to-Hospital in Australia and Norway in January 2014. "Geographic expansion continue
Read more →LMATLeMaitre Vascular to Present at the Benchmark Company Micro Cap Discovery Conference on Wednesday, December 11, 2013
BURLINGTON, Mass., Nov. 27, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in the Benchmark Company Micro Cap Discovery Conference at the Palmer House Hilton, Chicago, IL, on Wednesday, December 11, 2013. JJ Pellegrino
Read more →LMATLeMaitre Vascular Announces Appointment of Michael Thomas to Its Board of Directors
BURLINGTON, Mass., Nov. 11, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today changes in the composition of its Board of Directors. The Board has appointed Michael H. Thomas to its board of dir
Read more →LMATLeMaitre Vascular to Participate in Two Investor Conferences in November 2013
BURLINGTON, Mass., Nov. 8, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in two upcoming Investor Conferences. The first is the Three Part Advisors Southwest IDEAS Investor Conference at the Sheraton Dallas Hotel in D
Read more →LMATLeMaitre Vascular Announces Details for Its November 12th & 13th Investor and Analyst Days
BURLINGTON, Mass., Nov. 6, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that it will webcast its investor and analyst days to be held on November 12th and 13th. These events will be hosted
Read more →LMATLeMaitre Q3 2013 Sales $15.3mm (+12%)
BURLINGTON, Mass., Oct. 29, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today reported Q3 2013 financial results. The Company posted sales of $15.3mm and operating income of $0.8mm. The Company also annou
Read more →LMATLeMaitre Vascular to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum on Thursday, November 14, 2013
BURLINGTON, Mass., Oct. 25, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the Canaccord Genuity Medical Technology & Diagnostics Forum at the Westin Grand Central in New York, NY, on Thursday, November 14, 2013. George W. LeMaitre, Chairman & CEO
Read more →LMATLeMaitre Vascular Will Announce Third Quarter 2013 Earnings Results on October 29, 2013
BURLINGTON, Mass., Oct. 2, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), announced today that it will release its third quarter 2013 financial results on October 29, 2013, after the market close. The company has scheduled a conference call for 5:00 PM ET the sam
Read more →LMATLeMaitre Vascular to Host Two Investor and Analyst Days: November 12 & 13, 2013
BURLINGTON, Mass., Sept. 11, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that it will host November 2013 investor and analyst days in two locations: Tuesday, November 12, 9:30 AM to 1:00
Read more →LMATLeMaitre Vascular to Present at the Stifel Healthcare Conference 2013 on Thursday, September 12, 2013
BURLINGTON, Mass., Sept. 3, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the Stifel Healthcare Conference 2013 at the Four Seasons Hotel in Boston, MA, on Thursday, September 12, 2013. David Roberts, President, will provide an update on the Comp
Read more →LMATLeMaitre Vascular Acquires InaVein
BURLINGTON, Mass., Aug. 28, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that it acquired the assets of InaVein, LLC for $2.5mm, or 1.1X InaVein's 2012 sales, and potential earn-out payment
Read more →LMATLeMaitre Vascular to Present at the 6th Annual Barrington Research Growth Conference on Wednesday, September 4, 2013
BURLINGTON, Mass., Aug. 23, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the 6th Annual Barrington Research Growth Conference at the Four Seasons Hotel in Chicago, IL. JJ Pellegrino, Chief Financial Officer, will provide an update on the Company
Read more →LMATLeMaitre Vascular to Present at the Three Part Advisors Midwest IDEAS Investor Conference on Tuesday, August 27, 2013
BURLINGTON, Mass., Aug. 14, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the Three Part Advisors Midwest IDEAS Investor Conference at the University of Chicago, Gleacher Center in Chicago, IL. JJ Pellegrino, Chief Financial Officer, will provide
Read more →LMATLeMaitre Q2 2013 Record Sales $16mm (+12% Organic), Op. Income $1.4mm
BURLINGTON, Mass., July 30, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today reported Q2 2013 financial results. The Company posted record sales of $16.0mm and operating income of $1.4mm. The Company als
Read more →LMATLeMaitre Vascular to Present at the Canaccord Genuity 33rd Annual Growth Conference on Thursday, August 15, 2013
BURLINGTON, Mass., July 26, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the Canaccord Genuity 33rd Annual Growth Conference at the Intercontinental Hotel in Boston, MA. George W. LeMaitre, Chairman and CEO, will provide an update on the Company
Read more →LMATLeMaitre Vascular Will Announce Second Quarter 2013 Earnings Results on July 30, 2013
BURLINGTON, Mass., July 12, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), announced today that it will release its second quarter 2013 financial results on July 30, 2013, after the market close. The company has scheduled a conference call for 5:00 PM ET the same
Read more →LMATLeMaitre Vascular Acquires Clinical Instruments
BURLINGTON, Mass., July 9, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that on July 5, 2013 it acquired the assets of Clinical Instruments International, Inc. for $1.1mm, or 1.7X 2012 sale
Read more →LMATLeMaitre Launches 3 Products: 1.5mm Valvulotome, MultiTASC & AlboSure Patch
BURLINGTON, Mass., June 19, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today its third product launch since March. These three new products strengthen LeMaitre Vascular's position as a one-stop
Read more →LMATLeMaitre Vascular to Present at the Wells Fargo Securities 2013 Healthcare Conference on Wednesday, June 19, 2013
BURLINGTON, Mass., June 4, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the Wells Fargo Securities 2013 Healthcare Conference at the Intercontinental Hotel in Boston, MA. George W. LeMaitre, Chairman and CEO, will provide an update on the Compan
Read more →LMATLeMaitre Vascular to Present at the Sidoti & Company, LLC, Semi-Annual Microcap Conference on Friday, June 7, 2013
BURLINGTON, Mass., May 23, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the Sidoti & Company, LLC, Semi-Annual Microcap Conference at the Grand Hyatt Hotel in New York, NY. JJ Pellegrino, Chief Financial Officer, will present on the Company on F
Read more →LMATLeMaitre Vascular Ranked in Boston Globe Top 100 Businesses in Massachusetts
BURLINGTON, Mass., May 20, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, was ranked as #94 of the 100 best-performing publicly traded corporations based in Massachusetts by the Boston Globe. "I was thrille
Read more →LMATLeMaitre Vascular to Present at the Bank of America Merrill Lynch 2013 Health Care Conference on May 16th
BURLINGTON, Mass., May 9, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the Bank of America Merrill Lynch Health Care Conference at the Encore at Winn Hotel, Las Vegas, NV. George W. LeMaitre, CEO, will provide an update on the Company on Thursda
Read more →LMATLeMaitre Vascular to Present at the Three Part Advisors East Coast IDEAS Conference on May 15th
BURLINGTON, Mass., May 8, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the Three Part Advisors East Coast IDEAS Conference at the Metro Meeting Center in Boston, MA. David Roberts, President, will provide an update on the Company on Wednesday, M
Read more →LMATLeMaitre Q1 2013 Record Sales $15.4mm (+11% Organic), Op. Profit $1.1mm
BURLINGTON, Mass., April 30, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today reported Q1 2013 financial results. The Company posted record sales of $15.4mm and operating income of $1.1mm. The Company al
Read more →LMATLeMaitre Vascular to Present at the 12th Annual Needham Healthcare Conference on April 30th
BURLINGTON, Mass., April 23, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the 12th Annual Needham Healthcare Conference at the Westin Grand Central Hotel in New York, NY. David Roberts, President, will provide an update on the Company on Tuesday
Read more →LMATLeMaitre Vascular, Inc. Schedules First Quarter Results and Conference Call on April 30th
BURLINGTON, Mass., April 18, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its 2013 first quarter financial results on April 30, 2013, after the close of the market. In conjunction with the release, a conference call will be h
Read more →LMATLeMaitre Vascular to Present at the Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference on March 1st
BURLINGTON, Mass., Feb. 28, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference at the Snowbird Ski and Summer Resort in Snowbird, Utah. JJ Pellegrino, Chief Financial Officer
Read more →LMATLeMaitre Q4 2012 Sales $14.8mm (+12% Organic), Op. Profit $0.9mm
BURLINGTON, Mass., Feb. 26, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today reported Q4 2012 and full-year 2012 financial results. The Company posted Q4 sales of $14.8mm and operating income of $0.9mm,
Read more →LMATLeMaitre Vascular, Inc. Schedules Fourth Quarter Results and Conference Call
BURLINGTON, Mass., Feb. 14, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its 2012 fourth quarter and full year financial results on February 26, 2013, after the close of the market. In conjunction with the release, a conferen
Read more →LMATLeMaitre Vascular Announces Changes to Its Board of Directors
BURLINGTON, Mass., Dec. 10, 2012 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that in connection with Housatonic Partners' distribution of 1,393,314 LeMaitre Vascular shares to its limited partn
Read more →LMATLeMaitre Vascular to Open Toronto Office
BURLINGTON, Mass., Nov. 26, 2012 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced that it plans to increase its selling and marketing commitment in the Canadian market, and will be opening its Canadian he
Read more →LMATLeMaitre Vascular to Present at the Southwest IDEAS Investor Conference on November 15th
BURLINGTON, Mass., Nov. 12, 2012 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the Southwest IDEAS Investor Conference at the Sheraton Dallas Hotel, Dallas, TX. JJ Pellegrino, Chief Financial Officer, will provide an update on the Company on Thursday,
Read more →LMATLeMaitre Vascular to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
BURLINGTON, Mass., Nov. 9, 2012 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the Lazard Capital Markets 9th Annual Healthcare Conference at The Pierre Hotel, New York, NY. JJ Pellegrino, Chief Financial Officer, will provide an update on the Company
Read more →LMATLeMaitre Vascular to Present at the Brean Capital 2012 Life Sciences Summit
BURLINGTON, Mass., Nov. 1, 2012 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the Brean Capital 2012 Life Sciences Summit at the Sentry Centers, New York, NY. David Roberts, President, will provide an update on the Company on Wednesday, November 7, 20
Read more →LMATLeMaitre Q3 2012 Sales $13.65mm (+5% Organic), Op. Profit $1.0mm
- XenoSure Acquisition Completed - - Direct Sales Efforts in Canada and Switzerland - BURLINGTON, Mass., Oct. 30, 2012 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today reported Q3 2012 sales of $13.65mm and
Read more →LMATLeMaitre Vascular, Inc. Schedules Third Quarter Results and Conference Call
BURLINGTON, Mass., Oct. 17, 2012 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its 2012 third quarter financial results on October 30, 2012, after the close of the market. In conjunction with the release, a conference call will be
Read more →LMATLeMaitre Vascular to Sell Directly to Swiss Hospitals
BURLINGTON, Mass., Oct. 15, 2012 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that it will begin direct sales in Switzerland in December 2012. LeMaitre Vascular currently sells its products in S
Read more →LMATLeMaitre Vascular to Acquire XenoSure Rights for $4.6mm
BURLINGTON, Mass., Oct. 1, 2012 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that it has signed an agreement to acquire the manufacturing and distribution rights to XenoSure from Neovasc, Inc. o
Read more →LMATLeMaitre Vascular to Host Analyst Day
BURLINGTON, Mass., Sept. 25, 2012 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) will host an Analyst Day to update the investment community on the Company, its growth initiatives and strategic priorities. Analyst Day will be held Tuesday, September 25, 2012 at Ruth's
Read more →LMATLeMaitre Vascular to Present at the Rodman & Renshaw 14th Annual Healthcare Conference
BURLINGTON, Mass., Sept. 6, 2012 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the Rodman & Renshaw 14th Annual Healthcare Conference at the Waldorf Astoria, New York, NY. George W. LeMaitre, Chairman & CEO, will provide an update on the Company on Tu
Read more →LMATLeMaitre Vascular to Present at the Stifel Nicolaus 2012 Healthcare Conference
BURLINGTON, Mass., Aug. 31, 2012 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the Stifel Nicolaus 2012 Healthcare Conference at the Four Seasons Hotel, Boston, MA. David Roberts, President, will provide an update on the Company on Thursday, September
Read more →LMATLeMaitre Vascular to Present at the 5th Annual Barrington Research Growth Conference
BURLINGTON, Mass., Aug. 30, 2012 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the 5th Annual Barrington Research Growth Conference at the Four Seasons Hotel, Chicago, IL. JJ Pellegrino, Chief Financial Officer, will provide an update on the Company o
Read more →LMATLeMaitre Vascular to Present at the Canaccord Genuity Annual Growth Conference
BURLINGTON, Mass., Aug. 8, 2012 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the Canaccord Genuity Annual Growth Conference at the InterContinental Hotel in Boston, MA. George W. LeMaitre, Chairman & CEO, will provide an update on the Company on Tues
Read more →LMATLeMaitre Q2 2012 Sales $14.4mm (+8% Organic), Op. Profit $1.5mm
BURLINGTON, Mass., July 31, 2012 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today reported Q2 2012 sales of $14.4mm and operating profit of $1.5mm. The Company also approved a quarterly cash dividend of $0.02
Read more →LMATLeMaitre Vascular Analyst Day Changed to September 25, 2012
BURLINGTON, Mass., July 25, 2012 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) has changed the date of Analyst Day to Tuesday, September 25, 2012 at Ruth's Chris Steakhouse, 148 W 51st Street, New York, NY. It will begin at 9:30 am EDT and conclude at 12:30pm EDT. The
Read more →LMATLeMaitre Vascular, Inc. Schedules Second Quarter Results and Conference Call
BURLINGTON, Mass., July 19, 2012 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its 2012 second quarter financial results on July 31, 2012, after the close of the market. In conjunction with the release, a conference call will be ho
Read more →LMATLeMaitre Vascular to Present at the JMP Securities Healthcare Conference
BURLINGTON, Mass., July 11, 2012 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the Seventh Annual JMP Securities Healthcare Conference at the Peninsula New York Hotel in New York, NY. David B. Roberts, President, will provide an update on the company
Read more →LMATLeMaitre Vascular to Host Analyst Day on September 26, 2012
BURLINGTON, Mass., July 9, 2012 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) will host an Analyst Day to update the investment community on the Company, its growth initiatives and strategic priorities. Analyst Day will be held Wednesday, September 26, 2012 at Ruth's
Read more →LMATLeMaitre Vascular to Present at the Sidoti & Company Micro Cap Conference and the Wells Fargo Securities 2012 Healthcare Conference
BURLINGTON, Mass., June 7, 2012 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the Sidoti & Company, LLC Semi-Annual NY Micro Cap Conference at the Grand Hyatt Hotel in New York, NY. Joseph P. Pellegrino, Chief Financial Officer, will provide an update
Read more →LMATLeMaitre Vascular to Present at the East Coast IDEAS 2012 Investor Conference
BURLINGTON, Mass., May 31, 2012 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the Three Part Advisors, LLC 2012 East Coast IDEAS Investor Conference at the Metro Meeting Center in Boston, MA. Joseph P. Pellegrino, Chief Financial Officer, will provide
Read more →LMATLeMaitre Vascular to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
BURLINGTON, Mass., May 10, 2012 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the Bank of America Merrill Lynch 2012 Health Care Conference at the Wynn in Las Vegas, NV. David B. Roberts, President, will provide an update on the company on Wednesday,
Read more →LMATLeMaitre Vascular Q1 2012 Sales $13.9mm (+8% Organic), Op. Profit $0.9mm
BURLINGTON, Mass., May 2, 2012 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today reported Q1 2012 financial results. The Company posted Q1 2012 sales of $13.9mm and operating income of $0.9mm. The Company also
Read more →LMATLeMaitre Vascular, Inc. Schedules First Quarter Results and Conference Call
BURLINGTON, Mass., April 20, 2012 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its 2012 first quarter financial results on May 2, 2012, after the close of the market. In conjunction with the release, a conference call will be host
Read more →LMATLeMaitre Vascular Q4 2011 Sales $13.4mm (+5% Organic), Op. Profit $0.8mm
BURLINGTON, Mass., Feb. 27, 2012 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today reported Q4 2011 and full-year 2011 financial results. The Company posted Q4 2011 sales of $13.4mm and operating income of $0.
Read more →LMATLeMaitre Vascular to Present at the Sidoti & Company Micro Cap Conference
BURLINGTON, Mass., Jan. 9, 2012 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the Sidoti & Company, LLC Semi-Annual NY Micro Cap Conference at the Grand Hyatt Hotel in New York, NY. David B. Roberts, President, will provide an update on the company on
Read more →LMATLeMaitre Vascular to Present at the Canaccord Genuity Cardiovascular Conference
BURLINGTON, Mass., Dec. 1, 2011 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), is presenting at the Canaccord Genuity 6th Annual Cardiovascular Conference at the St. Regis Hotel in San Francisco, CA. JJ Pellegrino, Chief Financial Officer, will provide an update on th
Read more →LMATLeMaitre Vascular Doubles Its Stock Repurchase Program From $5mm to $10mm
BURLINGTON, Mass., Nov. 9, 2011 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today announced that its Board of Directors has doubled its stock repurchase authorization to an aggregate of $10mm of its Common Sto
Read more →LMATLeMaitre Vascular Q3 2011 Sales $14.6mm (+7%), Op. Income $2.0mm
BURLINGTON, Mass., Oct. 27, 2011 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today reported Q3 2011 financial results. The Company posted sales of $14.6mm and operating income of $2.0mm. The Company also decla
Read more →LMATLeMaitre Vascular to Present at the Stifel Nicolaus Healthcare Conference 2011
BURLINGTON, Mass., Aug. 29, 2011 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), is presenting at the Stifel Nicolaus Healthcare Conference 2011 at the Four Seasons Hotel in Boston, MA. JJ Pellegrino, Chief Financial Officer, will provide an update on the company on We
Read more →LMATLeMaitre Vascular Q2 2011 Record Sales of $15.1mm, Up 7%
BURLINGTON, Mass., July 28, 2011 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today reported Q2 2011 financial results. The Company posted record quarterly sales of $15.1mm, an operating profit of $0.9mm and an
Read more →LMATLeMaitre Vascular to Present at the Lazard Capital Markets Medical Technology Conference and the Wells Fargo Securities 2011 Healthcare Conference in June
BURLINGTON, Mass., June 14, 2011 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) will be presenting at the Lazard Capital Markets Medical Technology Conference on Monday, June 20, 2011, at the MGM Grand at Foxwoods in Mashantucket, CT. JJ Pellegrino, Chief Financial Off
Read more →LMATLeMaitre Vascular Ranked #48 of the 100 Best of Massachusetts Businesses
BURLINGTON, Mass., May 27, 2011 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, was ranked as #48 of the 100 Best of Massachusetts businesses by the Boston Globe. The Globe 100 ranks the best-performing publicly t
Read more →LMATLeMaitre Vascular to Present at the East Coast IDEAS Conference
BURLINGTON, Mass., May 27, 2011 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the East Coast IDEAS Conference on Wednesday, June 1, 2011, at the Metro Meeting Center in Boston, MA. JJ Pellegrino, Chief Financial Officer, will provide an update on the
Read more →LMATLeMaitre Vascular to Present at the Security Research Associates 7th Annual Spring Growth Stock Conference
BURLINGTON, Mass., May 23, 2011 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the Security Research Associates 7th Annual Spring Growth Stock Conference on Tuesday, May 24, 2011, at the Omni Hotel in San Francisco, CA. Brian Kickham, Business Developm
Read more →LMATLeMaitre to Consolidate California Factory; Also Exiting TAArget/Unifit Business
BURLINGTON, Mass., May 20, 2011 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today announced a new factory consolidation and its exit from its TAArget/Unifit stent graft business. California Factory Consolidat
Read more →LMATLeMaitre Vascular Q1 2011 Record Sales of $14.6mm, Up 6%
BURLINGTON, Mass., April 28, 2011 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today announced Q1 2011 financial results. The Company announced record quarterly sales of $14.6mm and an adjusted operating profit
Read more →LMATLeMaitre Vascular to Present at the Cowen & Company 31st Annual Healthcare Conference and the Roth Capital Partners 23rd Annual OC Growth Stock Conference in March
BURLINGTON, Mass., March 3, 2011 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at Cowen & Company's 31st Annual Healthcare Conference on Monday, March 7, 2011, at the Marriott Copley Place in Boston, MA. David B. Roberts, President, will provide an updat
Read more →LMATLeMaitre Q4 Sales $14.4mm (+9% Organic); 2010 Sales $56.1mm (+12% Organic)
BURLINGTON, Mass., Feb. 28, 2011 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today announced Q4 2010 financial results. The Company posted record quarterly sales of $14.4mm and adjusted operating income of $93
Read more →LMATLeMaitre Vascular to Present at Investment Conferences in January
BURLINGTON, Mass., Jan. 4, 2011 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is scheduled to present at the Sidoti Semiannual New York Micro Cap Conference on Monday, January 10, 2011, at the Grand Hyatt Hotel New York. JJ Pellegrino, CFO, will provide an update on t
Read more →LMATLeMaitre Vascular to Host Analyst Day on December 2, 2010
BURLINGTON, Mass., Nov. 29, 2010 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, will host an Analyst Day to update the investment community on the Company, its growth initiatives and strategic priorities, and to
Read more →LMATLeMaitre Vascular to Present at December Investment Conferences
BURLINGTON, Mass., Nov. 29, 2010 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is scheduled to present at the Canaccord Genuity 5th Annual Cardiovascular, Diabetes & Obesity Conference on Tuesday, December 7, 2010, at the Nikko Hotel in San Francisco, CA. JJ Pellegrin
Read more →LMATLeMaitre Vascular Acquires Lifespan Vascular Graft
BURLINGTON, Mass., Nov. 17, 2010 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of disposable and implantable peripheral vascular devices, announced today that it has acquired the Lifespan Vascular Graft manufacturing business from Angiotech Pharmaceuticals
Read more →LMATLeMaitre Vascular to Present at November Investment Conferences in NYC
BURLINGTON, Mass., Nov. 5, 2010 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is scheduled to present at the Lazard Capital Markets 7th Annual Healthcare Conference on Tuesday, Nov 16, 2010, at the St Regis in New York City. J.J. Pellegrino, CFO, will provide an updat
Read more →LMATLeMaitre Vascular Q3 2010 Sales $13.7mm (+6% Organic) and Record Op. Income $2.0mm
BURLINGTON, Mass., Oct. 28, 2010 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today announced Q3 2010 financial results. The Company posted sales of $13.7mm, a 76.1% gross margin and record operating income of
Read more →LMATLeMaitre Vascular to Present at Rodman & Renshaw Annual Global Investment Conference
BURLINGTON, Mass., Aug. 31, 2010 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that it will present at the healthcare track of the Rodman & Renshaw Annual Global Investment Conference at the New
Read more →LMATLeMaitre Vascular to Present at the Canaccord Genuity 30th Annual Growth Conference
BURLINGTON, Mass., July 30, 2010 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that it will present at the Canaccord Genuity 30th Annual Growth Conference at the InterContinental Hotel in Boston,
Read more →LMATLeMaitre Vascular Q2 2010 Sales $14.2mm (+15% Organic) and Op. Profit $2.0mm
BURLINGTON, Mass., July 28, 2010 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today announced Q2 2010 financial results. The Company posted record quarterly sales of $14.2mm and record quarterly operating incom
Read more →LMATLeMaitre Vascular to Present at Sidoti & Company's Semi-Annual New York Micro-Cap Conference
BURLINGTON, Mass., June 14, 2010 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that it will present at Sidoti & Company's Semi-Annual New York Micro-Cap Conference at the Grand Hyatt New York. Da
Read more →LMATLeMaitre Vascular to Present at the Wells Fargo Securities 2010 Healthcare Conference
BURLINGTON, Mass., June 11, 2010 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that it will present at the Wells Fargo Securities 2010 Healthcare Conference at the InterContinental Hotel in Bosto
Read more →LMATLeMaitre Vascular to Present at Needham & Company's 9th Annual Healthcare Conference
BURLINGTON, Mass., May 24, 2010 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that it will present at Needham & Company's 9th Annual Healthcare Conference at The New York Palace Hotel, New York,
Read more →LMATLeMaitre Vascular Q1 2010 Record Sales $13.8mm (+22%), Op. Profit $1.3mm
BURLINGTON, Mass., April 29, 2010 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today announced Q1 2010 financial results. The Company posted record quarterly sales of $13.8 million and operating income of $1.3
Read more →LMATLeMaitre Vascular Q4 2009 Record Sales $13.6mm (+12%), Op. Profit $1.2mm
BURLINGTON, Mass., March 4, 2010 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today announced Q4 and full year 2009 financial results. The Company posted record quarterly sales of $13.6 million, operating incom
Read more →LMATLeMaitre Vascular to Present at Cowen's 30th Annual Health Care Conference and Roth's 22nd Annual OC Growth Stock Conference in March
BURLINGTON, Mass., March 1, 2010 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is scheduled to present at Cowen and Company's 30th Annual Health Care Conference on Tuesday, March 9, 2010, at the Marriott Copley Place in Boston, MA. George W. LeMaitre, Chairman and CEO
Read more →LMATLeMaitre Vascular to Present at the Equities and C.K. Cooper Winter Discovery Day Conference
BURLINGTON, Mass., Dec. 10, 2009 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that it will present at the Equities Magazine and C.K. Cooper & Company Winter Discovery Day Conference at The Princ
Read more →LMATLeMaitre Vascular to Present at Canaccord Adams 3rd Annual Cardiovascular Conference
BURLINGTON, Mass., Oct. 30, 2009 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that it will present at the Canaccord Adams 3rd Annual Cardiovascular Conference in San Francisco, CA on Tuesday, No
Read more →LMATLeMaitre Vascular Q3 2009 Record Sales $13.3mm (up 11%), Op. Profit $1.3mm
BURLINGTON, Mass., Oct. 28, 2009 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today announced Q3 2009 financial results, posting record quarterly sales of $13.3 million, record operating income of $1.3 million
Read more →LMATLeMaitre Vascular Announces Extension of Endologix Powerlink Distribution
BURLINGTON, Mass., Aug. 11, 2009 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today announced that is has extended its exclusive distribution of the Endologix Powerlink(r) System in twelve European countries th
Read more →LMATLeMaitre Vascular to Present at Canaccord Adams 29th Annual Global Growth Conference
BURLINGTON, Mass., Aug. 6, 2009 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that it will present at the Canaccord Adams 29th Annual Global Growth Conference in Boston, MA on Tuesday, August 11,
Read more →LMATLeMaitre Vascular Q2 2009 Operating Profit of $1mm, Stock Buyback of $1mm
BURLINGTON, Mass., July 29, 2009 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today announced Q2 2009 financial results. Record profitability and operational cash flow in the quarter were due to continued expen
Read more →LMATLeMaitre Vascular Reports 3rd Consecutive Profitable Quarter (Excluding AlboGraft Charge)
BURLINGTON, Mass., April 28, 2009 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced Q1 2009 financial results, highlighted by continued sales growth in direct-to-hospital markets, gross margin expansion, a
Read more →LMATLeMaitre Vascular to Participate in Cowen's 29th Annual Health Care Conference
BURLINGTON, Mass., March 10, 2009 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), which develops, manufactures, and markets medical devices and implants for the treatment of peripheral vascular disease, is scheduled to participate in Cowen and Company's 29th Annual Hea
Read more →LMATLeMaitre Vascular Q4 2008 Sales Up 9% to $12.1 Million; Op. Profit of $354,000
BURLINGTON, Mass., March 3, 2009 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today announced Q4 and full year 2008 financial results. The Company also announced it has entered into a definitive agreement with
Read more →LMATLeMaitre Vascular to Present At the Rodman & Renshaw 10th Annual Healthcare Conference
BURLINGTON, Mass., Nov. 5, 2008 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), which develops, manufactures, and markets medical devices and implants for the treatment of peripheral vascular disease, announced today that it will present at the Rodman & Renshaw 10th An
Read more →LMATLeMaitre Q3 2008 Sales Up 19 Percent to $12.0 Million; Op. Profit of $170,000
BURLINGTON, Mass., Oct. 29, 2008 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today announced Q3 2008 financial results. Q3 2008 revenues were $12.0 million, a 19% increase over Q3 2007. Revenues increased 24%
Read more →LMATLeMaitre Vascular to Present At The Third Annual JMP Securities Healthcare Focus Conference
BURLINGTON, Mass., Sept. 30, 2008 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), which develops, manufactures, and markets medical devices and implants for the treatment of peripheral vascular disease, announced today that it will present at The Third Annual JMP Secur
Read more →LMATLeMaitre Vascular Appoints John J. O'Connor to Its Board of Directors
BURLINGTON, Mass., Sept. 19, 2008 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) today announced that John J. O'Connor has been appointed to its Board of Directors. Prior to his retirement in 2006, O'Connor was vice chairman of services for PricewaterhouseCoopers LLP (
Read more →LMATLeMaitre Vascular to Present At Canaccord Adams 28th Annual Global Growth Conference
BURLINGTON, Mass., Aug. 11, 2008 (PRIME NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), which develops, manufactures, and markets medical devices and implants for the treatment of peripheral vascular disease, announced today that it will present at the Canaccord Adams 28th An
Read more →LMATLeMaitre Vascular Receives Notice of Noncompliance With Nasdaq Marketplace Rule
BURLINGTON, Mass., Aug. 8, 2008 (PRIME NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today announced that it received a letter on August 6, 2008, from The Nasdaq Stock Market ("Nasdaq") indicating that it no longer com
Read more →LMATLeMaitre Vascular Reports Q2 2008 Revenue of $12.7 Million, a 23% Increase
BURLINGTON, Mass., July 29, 2008 (PRIME NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today announced financial results for Q2 2008. Q2 2008 revenues were $12.7 million, a 23% increase over Q2 2007. Revenues increased
Read more →Competitive Position
How LMAT ranks across every disease it competes inCompetitive Position is a premium feature
See how LMAT ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial